Key result
Novel platelet inhibitors may reduce platelet-related disorders by controlling platelet activation.
Why the study?
Much remains unclear regarding the factors regulating platelet activation and the role played by platelets in the origins of cardiovascular diseases.
A better understanding of platelet activation and the use of recently developed inhibitors may reduce the impact of platelet-related cardiovascular disorders.
May guide platelet inhibitor development in vascular disease; leaves open precise roles in disease origins.
Platelets play a vital role in the maintainance of vascular integrity in health as well as in disease. However, in addition they are now suspected to have a wide range of other functions and to be involved in the origins and development of several disease states. Platelet activation is necessary for physiological function but the delicate balance regulating the threshhold for activation and the reversal of activation can be disturbed by many factors. A better understanding of these factors and the ability to control platelet activity by a range of recently developed inhibitors should reduce the impact of platelet-related disorders. Nevertheless, there is much that is still unclear about the part played by platelets in the origins of cardiovascular diseases.
No takes yet. Share an insight, caveat, or question.
Clemetson et al. (1998) conducted a review in Cardiovascular diseases. Platelet inhibitors was evaluated. Platelet activation plays a vital role in vascular integrity and disease development, and controlling platelet activity with recently developed inhibitors may reduce platelet-related disorders.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: